Insights On Outsourced Drug Development

31. Advancing Drug Development Through Expertise In Energetic Chemistry 12/5/2025

    Overcoming development complexity requires robust process safety. Solutions can safely scale challenging reactions, like click chemistry and cryogenic organometallics, improving efficiency and results.

32. Why CDMO Performance Drops Exactly When It Matters Most 6/15/2026

    Programs often stall moving to GMP due to fragmented workflows and knowledge gaps. Aligning teams and integrating development with execution, via continuous data, sustains momentum and reduces risk.

33. Simplify And Streamline Method Development With In Silico Modeling 5/19/2026

    Automated screening paired with in silico modeling can cut method development time while improving robustness. See how combining experimentation and simulation enables faster decision‑making.

34. White Paper: Characterization Of Spray Dried Biologics 5/7/2025

    Discover how spray drying can transform the formulation of complex biologics by improving stability, delivery, and functionality, with insights into the critical techniques and strategies needed for successful development.

35. High-Throughput 90-Minute ELISA 9/17/2024

    Discover how one solution can be utilized to measure Human IgG and human IFN gamma, which are key targets in pharmacokinetic studies and immunotherapeutic drug safety testing, in just 90 minutes.

36. Maximizing Laboratory Efficiency With Automated Dual-Thermal Cycling 3/26/2026

    Accelerate tRNA lead discovery with automated digital PCR. Process 384 samples daily with minimal hands-on time, using dual thermal cyclers to scale from in vitro screening to clinical trials.

37. Aggregation In Antibody-Drug Conjugates: Causes And Mitigation 9/1/2025

    Discover how early intervention in ADC development can streamline clinical progress, ensure stability and safety, and accelerate commercialization with expert guidance.

38. A Study To Assess Organoid Size And Cell Count From 3D Image Analysis 4/4/2025

    Recent advancements in 3D patient-derived organoids (PDOs) offer improved predictive power over traditional 2D assays. Explore a patented bioprocess for PDO expansion that could revolutionize drug discovery, especially in oncology.

39. High-Throughput IgG Quantification Assay For Cell Line Development 4/4/2025

    Monoclonal antibodies are revolutionizing treatment for various diseases, which include cancer and autoimmune disorders. Discover how improving production methods can reduce costs and enhance accessibility.

40. Matrix Approach Enhances Potency Assay Development For ATMPs 12/22/2025

    Potency assays for ATMPs demand precision. Learn how a matrix approach, regulatory alignment, and advanced technologies can overcome variability and ensure safety throughout the product lifecycle.